Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Present status of brachytherapy].

S Hahimoto, T Dokiya

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |April 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    High dose rate remote-afterloading intracavitary irradiation (RALS) is a standard uterine cervix cancer treatment in Japan. Newer radioactive sources like Iridium-192 are replacing radium for safer, more effective interstitial radiotherapy across various cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Brachytherapy for prostate cancer in Japan.

    International journal of urology : official journal of the Japanese Urological Association·2001
    Same author

    [The brachytherapy with low dose-rate iridium for prostate cancer].

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2000
    Same author

    [Brachytherapy].

    Nihon rinsho. Japanese journal of clinical medicine·2000
    Same author

    Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.

    International journal of radiation oncology, biology, physics·1999
    Same author

    High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.

    International journal of radiation oncology, biology, physics·1999
    Same author

    Curative radiotherapy with high-dose-rate brachytherapy boost for localized esophageal carcinoma: dose-effect relationship of brachytherapy with the balloon type applicator system.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·1999

    Area of Science:

    • Oncology
    • Radiotherapy
    • Medical Physics

    Context:

    • Intracavitary and interstitial radiotherapy techniques are crucial in cancer treatment.
    • Remote-afterloading intracavitary irradiation (RALS) is established for uterine cervix carcinoma in Japan.
    • Traditional radium sources in interstitial radiotherapy present safety and handling challenges.

    Purpose:

    • To discuss high dose rate remote-afterloading intracavitary irradiation (RALS) and low dose rate interstitial irradiation.
    • To highlight the shift from radium to modern radioactive sources for interstitial radiotherapy.
    • To review the applications of Iridium-192 in treating various cancers.

    Summary:

    • RALS is a standard treatment for uterine cervix carcinoma in Japan.
    • Radioactive sources like Cobalt-60, Iodine-125, Cesium-137, and Iridium-192 are replacing radium due to improved safety and suitability for afterloading.

    Related Experiment Videos

  • Iridium-192 is increasingly used for intraoral, rectal, breast, and bile duct cancers.

    • Impact:

    • Facilitates safer and more effective radiotherapy practices.
    • Expands treatment options for various malignancies.
    • Improves patient outcomes through advanced radiation delivery methods.